Allcyte

Vienna, Austria Founded: 2017 • Age: 9 yrs Acquired By Exscientia
Developer of drugs for the treatment of cancer patients
Request Access

About Allcyte

Allcyte is a company based in Vienna (Austria) founded in 2017 was acquired by Exscientia in June 2021.. Allcyte has raised $6 million across 2 funding rounds from investors including Exscientia, EIT Health and 42 Capital. Allcyte operates in a competitive market with competitors including DINmotion and Drug Dosing Predictions, among others.

  • Headquarter Vienna, Austria
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6 M (USD)

    in 2 rounds

  • Latest Funding Round
    $6 M (USD), Seed

    Mar 25, 2021

  • Investors
    Exscientia

    & 6 more

  • Employee Count
    Employee Count
  • Acquired by
    Exscientia

    (Jun 15, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Allcyte

Allcyte has successfully raised a total of $6M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $6 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $6.0M
  • First Round
  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2021 Amount Seed - Allcyte Valuation 42 Capital , Air Street Capital
Jul, 2020 Amount Grant - Allcyte Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Allcyte

Allcyte has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Exscientia, EIT Health and 42 Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage technology companies are invested in across Europe.
Founded Year Domain Location
Venture capital firm investing in AI & life science sectors
Founded Year Domain Location
Amino Collective is engaged in backing innovative startup founders.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Allcyte

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Allcyte

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Allcyte Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Allcyte

Allcyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DINmotion and Drug Dosing Predictions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Offers PBPK models and data solutions for optimizing pharmaceutical drug development processes.
domain founded_year HQ Location
Offers comprehensive tools for informed drug development and dosing predictions.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Allcyte

Frequently Asked Questions about Allcyte

When was Allcyte founded?

Allcyte was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is Allcyte located?

Allcyte is headquartered in Vienna, Austria.

Is Allcyte a funded company?

Allcyte is a funded company, having raised a total of $6M across 2 funding rounds to date.

What does Allcyte do?

Developer of drugs for the treatment of cancer patients. It offers Pharmacoscopy high-content imaging platform that supports pre-clinical drug development and clinical decision making services. It enables research through the image-based quantification of single-cell phenotypes. It helps pharmaceutical companies to locate the most promising indications for their drug candidates, and doctors use it to find the correct drug for the right patients.

Who are the top competitors of Allcyte?

Allcyte's top competitors include DINmotion and Drug Dosing Predictions.

Who are Allcyte's investors?

Allcyte has 7 investors. Key investors include Exscientia, EIT Health, 42 Capital, Air Street Capital, and PUSH VC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available